603883.SH
老百姓
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 13.01
−1.44%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
20.3x
EV/EBITDA
9.3x
Market Cap
CNY 9.87B
MomentumView details →
1D Return
−1.44%
YTD Return
−8.99%
RSI (14)
59.2
ValuationView details →
P/E (Fwd)
20.3x
EV/EBITDA
9.3x
Market Cap
CNY 9.87B
RSI (14)
59.2
MomentumView details →
1D Return
−1.44%
YTD Return
−8.99%
Similar companies
Latest newsMore news →
Laobaixing announced a share buyback plan of 40 million to 80 million yuan.3d agoLaobaixing announced a cash dividend of 0.3 yuan per share (including tax), totaling 228 million yuan (including tax).9d agoLaobaixing announced its first-half 2026 results: revenue of 10.998 billion yuan, up 2.07% year-on-year; net profit attributable to shareholders of 447 million yuan, up 12.30% year-on-year; non-recurring net profit of 436 million yuan, up 14.48% year-on-year.9d ago